Nerivio Device Cleared for Migraine Prevention
The FDA has cleared Nerivio for the preventative treatment of migraine with or without aura in patients 12 years of age and older.
Stay updated with breaking news from Accessed March. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has cleared Nerivio for the preventative treatment of migraine with or without aura in patients 12 years of age and older.
The FDA has approved new single-dose prefilled syringes for Emerphed (ephedrine sulfate) for clinically important hypotension.
The FDA has cleared Nerivio for the preventative treatment of migraine with or without aura in patients 12 years of age and older.
Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities...
ND0612, a continuous 24 hours/day subcutaneous (SC) infusion?of liquid levodopa/carbidopa (LD/CD), showed superior efficacy compared to oral LD/CD for the primary endpoint ("ON" time without